Cargando…

Pharmacotherapy for multidrug resistant tuberculosis

The current global concern in the treatment of tuberculosis (TB) is the emergence of resistance to the two most potent drugs namely, isoniazid and rifampicin. Emergence of multidrug resistance tuberculosis (MDR-TB) is now a health problem faced by most of the developing countries as well as develope...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chhabra, Naveen, Aseri, M. L., Dixit, Ramakant, Gaur, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Educational Forum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356975/ https://www.ncbi.nlm.nih.gov/pubmed/22629081 http://dx.doi.org/10.4103/0976-500X.95502

Ejemplares similares

Analysis of thyroid function tests in patients of multidrug resistance tuberculosis undergoing treatment
por: Chhabra, Naveen, et al.
Publicado: (2011)

The Growing Problem of Multidrug-Resistant Tuberculosis in North Korea
por: Seung, Kwonjune J., et al.
Publicado: (2013)

Chemically modified tetracyclines: Novel therapeutic agents in the management of chronic periodontitis
por: Agnihotri, Rupali, et al.
Publicado: (2012)

Data management in clinical research: An overview
por: Krishnankutty, Binny, et al.
Publicado: (2012)

Randomized Trials to Optimize Treatment of Multidrug-Resistant Tuberculosis: The time for action is now
por: Mitnick, Carole D, et al.
Publicado: (2007)

Laboratory costs of diagnosing TB in a high multidrug-resistant TB setting
por: Cates, L., et al.
Publicado: (2021)

Reversing resistance: The next generation antibacterials
por: Shah, Neel Jayesh
Publicado: (2015)

The Movement of Multidrug-Resistant Tuberculosis across Borders in East Africa Needs a Regional and Global Solution
por: Cain, Kevin P., et al.
Publicado: (2015)

Global Financing and Long-Term Technical Assistance for Multidrug-Resistant Tuberculosis: Scaling Up Access to Treatment
por: Hwang, Thomas J., et al.
Publicado: (2014)

Multidrug-resistant tuberculosis/rifampicin-resistant tuberculosis: Principles of management
por: Prasad, Rajendra, et al.
Publicado: (2018)

Costs of treating multidrug-resistant TB in California in 2022
por: Katrak, S., et al.
Publicado: (2023)

Artificial sweeteners as a sugar substitute: Are they really safe?
por: Sharma, Arun, et al.
Publicado: (2016)

Cost-effective innovation of locally assembled mannequins for undergraduate skill development in parenteral drug administration
por: Mani, Susan, et al.
Publicado: (2020)

Sputum culture conversion definitions and analytic practices for multidrug-resistant TB
por: Rodriguez, C. A., et al.
Publicado: (2021)

Pediatric Sepsis Guidelines: Summary for resource-limited countries
por: Khilnani, Praveen, et al.
Publicado: (2010)

Pharmacotherapy of chronic obstructive pulmonary disease: Therapeutic considerations with a focus on inhaled corticosteroids
por: Irusen, Elvis M., et al.
Publicado: (2020)

Renin angiotensin system: A novel target for migraine prophylaxis
por: Nandha, Ruchika, et al.
Publicado: (2012)

Antiretroviral drugs: Critical issues and recent advances
por: Desai, Mira, et al.
Publicado: (2012)

Biosimilars: Current perspectives and future implications
por: Misra, Monika
Publicado: (2012)

Use of Bayesian statistics in drug development: Advantages and challenges
por: Gupta, Sandeep K
Publicado: (2012)

Basic biostatistics for post-graduate students
por: Dakhale, Ganesh N., et al.
Publicado: (2012)

The treatment strategies of autoimmune disease may need a different approach from conventional protocol: A review
por: Chandrashekara, S.
Publicado: (2012)

Vaptans: A new option in the management of hyponatremia
por: Aditya, Suruchi, et al.
Publicado: (2012)

Role of zinc in pediatric diarrhea
por: Bajait, Chaitali, et al.
Publicado: (2011)

New insights into molecular targets for urinary incontinence
por: Poonia, Manoj K., et al.
Publicado: (2010)

Non-inferiority clinical trials: Practical issues and current regulatory perspective
por: Gupta, Sandeep K.
Publicado: (2011)

Toxicological screening
por: Parasuraman, S.
Publicado: (2011)

Global challenges of graduate level Ayurvedic education: A survey
por: Patwardhan, Kishor, et al.
Publicado: (2010)

Inverse agonism and its therapeutic significance
por: Khilnani, Gurudas, et al.
Publicado: (2011)

Saxagliptin: A dipeptidyl peptidase-4 inhibitor in the treatment of type 2 diabetes mellitus
por: Dave, Darshan J.
Publicado: (2011)

Sugar substitutes: Health controversy over perceived benefits
por: Tandel, Kirtida R.
Publicado: (2011)

Vitamin-C as anti-Helicobacter pylori agent: More prophylactic than curative- Critical review
por: Pal, Jagannath, et al.
Publicado: (2011)

Newer molecules in the treatment of schizophrenia: A clinical update
por: Ghosh, Abhishek, et al.
Publicado: (2011)

Vitamin D as a promising anticancer agent
por: Chakraborti, Chandra Kanti
Publicado: (2011)

Role of coenzyme Q(10) as an antioxidant and bioenergizer in periodontal diseases
por: Prakash, Shobha, et al.
Publicado: (2010)

Ayurveda education: A student's perspective
por: Pathak, Namyata Y.
Publicado: (2010)

Clinical trials of antihypertensives: Nature of control and design
por: Chakraborty, Bhaswat S.
Publicado: (2011)

Animal models and biomarkers of neuropathy in diabetic rodents
por: Shaikh, A.S., et al.
Publicado: (2010)

Adaptive design clinical trials: Methodology, challenges and prospect
por: Mahajan, Rajiv, et al.
Publicado: (2010)

Angiogenesis: Future of pharmacological modulation
por: Bisht, Manisha, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_0bmjh81af578n66r7m3bokqdf7